EyePoint Pharmaceuticals
EYPT
EYPT
58 hedge funds and large institutions have $111M invested in EyePoint Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 19 increasing their positions, 13 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
6% more capital invested
Capital invested by funds: $104M → $111M (+$6.61M)
0.69% more ownership
Funds ownership: 5.8% → 6.48% (+0.69%)
16% less call options, than puts
Call options by funds: $140K | Put options by funds: $166K
Holders
58
Holding in Top 10
2
Calls
$140K
Puts
$166K
Top Buyers
| 1 | +$2.66M | |
| 2 | +$2.04M | |
| 3 | +$1.68M | |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
+$892K |
| 5 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
+$886K |
Top Sellers
| 1 | -$524K | |
| 2 | -$138K | |
| 3 | -$122K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$91.4K |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$65.3K |